Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$12.10
+1.94%
Mkt Cap $840.14M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (6 analysts)
$39.00
Range $38.00 – $40.00
Implied Upside
+222.3%
Consensus $39.00 vs current $12.10
NASDAQ·Healthcare·Biotechnology
$12.10
+1.94%
Mkt Cap $840.14M
Buy
3
Hold
0
Sell
0
Price Target (6 analysts)
$39.00
Range $38.00 – $40.00
+222.3%
Consensus $39.00 vs current $12.10